雜志介紹

Cellular Oncology雜志介紹

《Cellular Oncology》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱細胞腫瘤學，本刊主要出版、報道醫(yī)學-CELL BIOLOGY領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為4.9，最新CiteScore 指數(shù)為10.3。

本刊近期中國學者發(fā)表的論文主要有：

• Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b(+)CD64(+) patients with acute myeloid leukemia

  Author: Wang, Qian; Zhang, Nan; Liu, Li; Ma, Linlu; Tan, Yuxin; Liu, Xiaoyan; Wu, Jinxian; Chen, Guopeng; Li, Xinqi; Liang, Yuxing; Zhou, Fuling

• In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPAR gamma)

  Author: Wang, Jiahui; Chu, Hongjin; Wang, Zhixin; Wang, Xuebo; Liu, Xuexia; Song, Zhan; Liu, Fujun

• Research advances and treatment perspectives of pancreatic adenosquamous carcinoma

  Author: Zhang, Wen; Zhang, Jing; Liang, Xijun; Ding, Jin

• FUT8 is regulated by miR-122-5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling

  Author: Chen, Fanghua; Li, Yin; Aye, Ling; Wu, Yingcheng; Dong, Liangqing; Yang, Zijian; Gao, Qiang; Zhang, Shu

英文介紹

Cellular Oncology雜志英文介紹

The Official Journal of the International Society for Cellular Oncology

Focuses on translational research

Addresses the conversion of cell biology to clinical applications

Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.

In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.